SXI Life Sciences
7.772,36
PKT
-3,32
PKT
-0,04
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.06.18 | Roche buy | Jefferies & Company Inc. | |
| 13.06.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.06.18 | Roche market-perform | Bernstein Research | |
| 06.06.18 | Roche overweight | JP Morgan Chase & Co. | |
| 06.06.18 | Roche Reduce | HSBC | |
| 04.06.18 | Roche Underweight | Morgan Stanley | |
| 04.06.18 | Roche Hold | Deutsche Bank AG | |
| 04.06.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 04.06.18 | Roche overweight | JP Morgan Chase & Co. | |
| 31.05.18 | Roche Reduce | HSBC | |
| 31.05.18 | Novartis Hold | HSBC | |
| 30.05.18 | Roche Hold | Deutsche Bank AG | |
| 29.05.18 | Roche Conviction Buy | Goldman Sachs Group Inc. | |
| 29.05.18 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.05.18 | Roche overweight | JP Morgan Chase & Co. | |
| 29.05.18 | Roche buy | Baader Bank | |
| 29.05.18 | Roche buy | Jefferies & Company Inc. | |
| 29.05.18 | Novartis Hold | HSBC | |
| 25.05.18 | Novartis Neutral | Credit Suisse Group | |
| 25.05.18 | Roche Underperform | Credit Suisse Group | |
| 23.05.18 | Roche overweight | Barclays Capital | |
| 22.05.18 | Roche Hold | Deutsche Bank AG | |
| 22.05.18 | Roche buy | Jefferies & Company Inc. | |
| 22.05.18 | Novartis Underweight | Barclays Capital | |
| 22.05.18 | Roche Neutral | Citigroup Corp. | |
| 22.05.18 | Roche overweight | JP Morgan Chase & Co. | |
| 18.05.18 | Roche Neutral | UBS AG | |
| 17.05.18 | Novartis Hold | Deutsche Bank AG | |
| 17.05.18 | Novartis Neutral | JP Morgan Chase & Co. | |
| 17.05.18 | Roche overweight | JP Morgan Chase & Co. | |
| 15.05.18 | Roche overweight | JP Morgan Chase & Co. | |
| 14.05.18 | Roche Hold | Kepler Cheuvreux | |
| 14.05.18 | Novartis buy | Jefferies & Company Inc. | |
| 14.05.18 | Roche buy | Jefferies & Company Inc. | |
| 11.05.18 | Roche overweight | JP Morgan Chase & Co. | |
| 11.05.18 | Roche overweight | Barclays Capital | |
| 10.05.18 | Roche market-perform | Bernstein Research | |
| 07.05.18 | Novartis buy | Kepler Cheuvreux | |
| 27.04.18 | Novartis Neutral | UBS AG | |
| 27.04.18 | Roche Neutral | Credit Suisse Group |